JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Avita Therapeutics Inc

Geschlossen

4.65 -1.9

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.59

Max

4.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

1.6M

-12M

Verkäufe

554K

18M

Gewinnspanne

-65.968

Angestellte

226

EBITDA

1.6M

-9.7M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+32.7% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

30M

153M

Vorheriger Eröffnungskurs

6.55

Vorheriger Schlusskurs

4.65

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

23. Apr. 2026, 00:00 UTC

Wichtige Nachrichtenereignisse

Australian Flash PMI Bounce in April Conceals Deeper Worries

22. Apr. 2026, 23:33 UTC

Ergebnisse

SK Hynix Posts Record Quarterly Results Amid AI Boom

22. Apr. 2026, 22:40 UTC

Ergebnisse

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22. Apr. 2026, 22:10 UTC

Akquisitionen, Fusionen, Übernahmen

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22. Apr. 2026, 21:11 UTC

Ergebnisse

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22. Apr. 2026, 21:01 UTC

Ergebnisse

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22. Apr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22. Apr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22. Apr. 2026, 23:34 UTC

Market Talk
Wichtige Nachrichtenereignisse

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22. Apr. 2026, 23:16 UTC

Ergebnisse

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22. Apr. 2026, 23:15 UTC

Ergebnisse

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22. Apr. 2026, 22:54 UTC

Ergebnisse

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22. Apr. 2026, 22:54 UTC

Ergebnisse

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22. Apr. 2026, 22:52 UTC

Ergebnisse

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22. Apr. 2026, 22:51 UTC

Ergebnisse

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22. Apr. 2026, 22:31 UTC

Ergebnisse

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22. Apr. 2026, 22:31 UTC

Ergebnisse

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22. Apr. 2026, 22:30 UTC

Ergebnisse

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22. Apr. 2026, 22:30 UTC

Ergebnisse

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22. Apr. 2026, 22:29 UTC

Ergebnisse

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22. Apr. 2026, 22:28 UTC

Ergebnisse

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22. Apr. 2026, 22:28 UTC

Ergebnisse

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22. Apr. 2026, 22:27 UTC

Ergebnisse

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22. Apr. 2026, 22:06 UTC

Market Talk
Ergebnisse

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22. Apr. 2026, 21:55 UTC

Akquisitionen, Fusionen, Übernahmen

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22. Apr. 2026, 21:47 UTC

Ergebnisse

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22. Apr. 2026, 21:37 UTC

Ergebnisse

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22. Apr. 2026, 21:34 UTC

Ergebnisse

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22. Apr. 2026, 21:29 UTC

Ergebnisse

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22. Apr. 2026, 21:20 UTC

Market Talk
Ergebnisse

Tesla Expands Manufacturing to Chips -- Market Talk

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

32.7% Vorteil

12-Monats-Prognose

Durchschnitt 6.33 USD  32.7%

Hoch 10 USD

Tief 3.5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

2

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
help-icon Live chat